Report cover image

Transdermal Skin Patches Market, Size, Global Forecast 2022-2027, Industry Trends, Share, Growth, Insight, Impact of COVID-19, Company Analysis

Publisher Renub Research
Published Apr 01, 2022
Length 115 Pages
SKU # RNBR17136005

Description

Transdermal Skin Patches Market, Size, Global Forecast 2022-2027, Industry Trends, Share, Growth, Insight, Impact of COVID-19, Company Analysis

Global Transdermal Skin Patches Market is expected to reach US$ 9.6 Billion in 2027. Transdermal skin patches are a non-invasive and simple means of delivering steady and consistent therapeutic doses into the bloodstream over a set period. Backings, medicines, membranes, adhesives, liners, chemical enhancers and permeates, physical assistance, and low electrical current techniques such as iontophoresis are among them. Depending on the skin's properties and the patch's design, they provide a uniform diffusion rate. They are currently widely utilized worldwide as cosmetic, topical, and transdermal delivery systems.

The primary factors driving the transdermal skin patches market expansion are the rising benefits of transdermal medicine over oral and swallowing drugs (medications for gastrointestinal toxicity) that cause nausea and vomiting. They are less inconvenient than intravenous or parenteral therapies since they are non-invasive. The key benefit is that the patch allows for regulated drug release to the patient, usually accomplished by a perforated membrane covering the drug reservoir or by body warmth dissolving small layers of medication in the adhesive.

COVID-19 Outbreak Boosted the Transdermal Patch Market Size:

The COVID-19 outbreak has likely had a beneficial effect on the market for transdermal skin patches. These patches make it possible to administer medications to a specific skin microenvironment safely, repeatable, and regulated manner. As a result, researchers working on a potential COVID-19 vaccination were looking into using a fingertip-sized skin patch to deliver the vaccine. According to Renub Research, Global Transdermal Skin Patches Market Is Foreseen to Register a CAGR of 3.52% during 2021-2027.

Worldwide Transdermal Skin Patches Market Size was US$ 7.8 Billion in 2021.

The transdermal skin patches market is split by Type and Application in our analysis. Furthermore, the growth of these segments assists in the study of the industries' meagre growth. It provides a vital market overview and industry insights to aid in strategic decision-making to identify core market applications.

By Types, the Transdermal Skin Patches Market is divided into three types: Single Layer Drug Adhesive, Multi-Layer Drug Adhesive, and Matrix.

By Application, the Transdermal Skin Patches Market is divided into four categories: Pain Management, Hormonal Application, Central Nervous System Disorder, and Cardiovascular Diseases.

Transdermal Skin Patches Market Regional Level Analysis:

North America, Asia Pacific, Europe, and Rest of World are the critical regions in our transdermal skin patches market study. According to our research, North America dominates the transdermal patches market due to the increasing presence of key players and established healthcare infrastructure, increasing beneficial government initiatives, increasing the number of research partnerships, increasing the adoption of various strategies such as product innovation, and increasing product launches and approval in this region.

Competitive Landscape:

The market for transdermal skin patches is competitive. Leading companies focus on product innovations, product launches and approvals, R&D investment for advancements in transdermal patches, and mergers and acquisitions as developmental strategies to stay competitive in the industry. Teva Pharmaceutical Industries Ltd, Novartis AG, Mylan NV (Viatris), Luye Pharma Group, Bayer HealthCare Pharmaceuticals, Allergan, 3M Health Care Business Group, and Henan Lingrui Pharmaceutical Ltd are some of the key players in the market.

Renub Research latest report “Transdermal Skin Patches Market, Global Forecast By Type (Single Layer Drug Adhesive, Multi-Layer Drug Adhesive, and Matrix), Application (Pain Management, Hormonal Application, Central Nervous System Disorder, and Cardiovascular Diseases), Region (North America, Asia Pacific, Europe, and ROW), Companies (Teva Pharmaceutical Industries Ltd, Novartis AG, Mylan NV (Viatris), Luye Pharma Group, Bayer HealthCare Pharmaceuticals, Allergan, 3M Health Care Business Group, and Henan Lingrui Pharmaceutical Ltd)” provides a detailed analysis of Transdermal Skin Patches Industry.

Type - Market has been covered from 4 viewpoints:

1. Single Layer Drug Adhesive
2. Multi-Layer Drug Adhesive
3. Matrix
4. Others

Application - Market has been covered from 5 viewpoints:

1. Pain Management
2. Hormonal Application
3. Central Nervous System Disorder
4. Cardiovascular Diseases
5. Others

Regions - Market has been covered from 4 viewpoints:

1. North America
2. Asia Pacific
3. Europe
4. Rest of World

Company Insights:

• Company Profile
• Recent Developments
• Revenue

Companies Covered:

1. Teva Pharmaceutical Industries Ltd
2. Novartis AG
3. Mylan NV (Viatris)
4. Luye Pharma Group
5. Bayer HealthCare Pharmaceuticals
6. Allergan
7. 3M Health Care Business Group
8. Henan lingrui pharmaceutical ltd

Table of Contents

115 Pages
1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Global Transdermal Skin Patch Market
6. Market Share
6.1 By Type
6.2 By Application
6.3 By Regions
7. Type – Global Transdermal Skin Patches Market
7.1 Single Layer Drug Adhesive
7.2 Multi-Layer Drug Adhesive
7.3 Matrix
7.4 Others
8. Application – Global Transdermal Skin Patches Market
8.1 Pain Management
8.2 Hormonal Application
8.3 Central Nervous System Disorder
8.4 Cardiovascular Diseases
8.5 Others
9. Regions – Global Transdermal Skin Patches Market
9.1 North America
9.2 Asia Pacific
9.3 Europe
9.4 Rest of World
10. Porters Five Forces
10.1 Bargaining Power of Buyers
10.2 Bargaining Power of Suppliers
10.3 Degree of Competition
10.4 Threat of New Entrants
10.5 Threat of Substitutes
11. Company Analysis
11.1 Teva Pharmaceutical Industries Ltd
11.1.1 Company Profile
11.1.2 Recent Developments
11.1.3 Revenue
11.2 Novartis AG
11.2.1 Company Profile
11.2.2 Recent Developments
11.2.3 Revenue
11.3 Mylan NV (Viatris)
11.3.1 Company Profile
11.3.2 Recent Developments
11.3.3 Revenue
11.4 Luye Pharma Group
11.4.1 Company Profile
11.4.2 Recent Developments
11.4.3 Revenue
11.5 Bayer HealthCare Pharmaceuticals
11.5.1 Company Profile
11.5.2 Recent Developments
11.5.3 Revenue
11.6 Allergan
11.6.1 Company Profile
11.6.2 Recent Developments
11.6.3 Revenue
11.7 3M Health Care Business Group
11.7.1 Company Profile
11.7.2 Recent Developments
11.7.3 Revenue
11.8 Henan lingrui pharmaceutical ltd
11.8.1 Company Profile
11.8.2 Recent Developments
11.8.3 Revenue
List of Figures:
Figure-01: Global – Transdermal Skin Patch Market (Billion US$), 2017 – 2021
Figure-02: Global – Forecast for Transdermal Skin Patch Market (Billion US$), 2022 – 2027
Figure-03: Type – Single Layer Drug Adhesive Market (Million US$), 2017 – 2021
Figure-04: Type – Forecast for Single Layer Drug Adhesive Market (Million US$), 2022 – 2027
Figure-05: Type – Multi-Layer Drug Adhesive Market (Million US$), 2017 – 2021
Figure-06: Type – Forecast for Multi-Layer Drug Adhesive Market (Million US$), 2022 – 2027
Figure-07: Type – Matrix Market (Million US$), 2017 – 2021
Figure-08: Type – Forecast for Matrix Market (Million US$), 2022 – 2027
Figure-09: Type – Others Market (Million US$), 2017 – 2021
Figure-10: Type – Forecast for Others Market (Million US$), 2022 – 2027
Figure-11: Application – Pain Management Market (Million US$), 2017 – 2021
Figure-12: Application – Forecast for Pain Management Market (Million US$), 2022 – 2027
Figure-13: Application – Hormonal Application Market (Million US$), 2017 – 2021
Figure-14: Application – Forecast for Hormonal Application Market (Million US$), 2022 – 2027
Figure-15: Application – Central Nervous System Disorder Market (Million US$), 2017 – 2021
Figure-16: Application – Forecast for Central Nervous System Disorder Market (Million US$), 2022 – 2027
Figure-17: Application – Cardiovascular Diseases Market (Million US$), 2017 – 2021
Figure-18: Application – Forecast for Cardiovascular Diseases Market (Million US$), 2022 – 2027
Figure-19: Application – Others Market (Million US$), 2017 – 2021
Figure-20: Application – Forecast for Others Market (Million US$), 2022 – 2027
Figure-21: North America – Transdermal Skin Patch Market (Million US$), 2017 – 2021
Figure-22: North America – Forecast for Transdermal Skin Patch Market (Million US$), 2022 – 2027
Figure-23: Asia Pacific – Transdermal Skin Patch Market (Million US$), 2017 – 2021
Figure-24: Asia Pacific – Forecast for Transdermal Skin Patch Market (Million US$), 2022 – 2027
Figure-25: Europe – Transdermal Skin Patch Market (Million US$), 2017 – 2021
Figure-26: Europe – Forecast for Transdermal Skin Patch Market (Million US$), 2022 – 2027
Figure-27: Rest of World – Transdermal Skin Patch Market (Million US$), 2017 – 2021
Figure-28: Rest of World – Forecast for Transdermal Skin Patch Market (Million US$), 2022 – 2027
Figure-29: Teva Pharmaceutical Industries Ltd – Global Revenue (Million US$), 2017 – 2021
Figure-30: Teva Pharmaceutical Industries Ltd – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-31: Novartis AG – Global Revenue (Million US$), 2017 – 2021
Figure-32: Novartis AG – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-33: Mylan NV (Viatris) – Global Revenue (Million US$), 2017 – 2021
Figure-34: Mylan NV (Viatris) – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-35: Luye Pharma Group – Global Revenue (Million US$), 2017 – 2021
Figure-36: Luye Pharma Group – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-37: Bayer HealthCare Pharmaceuticals – Global Revenue (Million US$), 2017 – 2021
Figure-38: Bayer HealthCare Pharmaceuticals – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-39: Allergan – Global Revenue (Million US$), 2017 – 2021
Figure-40: Allergan – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-41: 3M Health Care Business Group – Global Revenue (Million US$), 2017 – 2021
Figure-42: 3M Health Care Business Group – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-43: Henan lingrui pharmaceutical ltd – Global Revenue (Million US$), 2017 – 2021
Figure-44: Henan lingrui pharmaceutical ltd – Forecast for Global Revenue (Million US$), 2022 – 2027
List of Tables:
Table-01: Global – Transdermal Skin Patch Market Share by Type (Percent), 2017 – 2021
Table-02: Global – Forecast for Transdermal Skin Patch Market Share by Type (Percent), 2022 – 2027
Table-03: Global – Transdermal Skin Patch Market Share by Application (Percent), 2017 – 2021
Table-04: Global – Forecast for Transdermal Skin Patch Market Share by Application (Percent), 2022 – 2027
Table-05: Global – Transdermal Skin Patch Market Share by Region (Percent), 2017 – 2021
Table-06: Global – Forecast for Transdermal Skin Patch Market Share by Region (Percent), 2022 – 2027

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us